2025 ADS Kellion Award

The Australian Diabetes Society (ADS) and Diabetes Australia (Kellion Advisory Council) invite applications for the 2025 ADS Kellion Award for an Australian who has demonstrated innovative leadership and has made an outstanding and highly original contribution to the advancement of knowledge in diabetes research, excellence in education, advocacy, clinical standards or services of care in diabetes in Australia. This is an annual award that commenced in the year 2000 and is the premier award bestowed on an individual by the ADS. Nominations are now called for this Award which will be considered by a review committee consisting of the ADS Council as well as prominent Australian diabetes experts and if appropriate international referees.

Nominations may be self-initiated, initiated by colleagues or by organisations. The recipient of the 2025 ADS Kellion Award must be a financial ADS member (paid subscription for 2025) and a member of the society for at least 12 months at time of nomination (must have joined as a member of ADS no later than April 2024). The recipient will be required to deliver the ADS Kellion Plenary Lecture at the 2025 Australasian Diabetes Congress (ADC) that will be held at the Gold Coast Convention and Exhibition Centre in QLD from Wednesday 20th to Friday 22nd August 2025. The Award will include a return business class airfare to the congress, accommodation for the duration of the meeting, full ADC registration, and a commemorative plaque. The award also includes a $10,000 honorarium.

Nominations should include a letter (not exceeding 2 pages) clearly stating the basis of the nomination and a full curriculum vitae of the nominee. Nominations made in the previous years have been retained and will be considered also.

2025 ADS Kellion Award nominations have now closed.

Nominations Closing Date: Monday, 28 April 2025 – CLOSED

2025 ADS Ranji and Amara Wikramanayake Clinical Diabetes Research Award

This Mid-Career Award supporting the career of a clinical diabetes researcher has been made possible by the generosity of the late Dr Ranji Wikramanayake, who was a long-standing member of the Australian Diabetes Society. The Australian Diabetes Society (ADS) invites applications for the 2025 ADS Ranji and Amara Wikramanayake Clinical Diabetes Research Award from endocrinology/diabetes clinicians who are members of the ADS and are up to 20 years’ post-doctoral degree or equivalent. Applications can be nominated by financial members of the ADS or by self-nomination. The award is to recognise significant contributions to diabetes research by a clinician and to support further advancement of those achievements. The successful candidate will deliver the ADS Ranji and Amara Wikramanayake Clinical Diabetes Award Lecture at the 2025 Australasian Diabetes Congress that will be held at the Gold Coast Convention and Exhibition Centre in QLD from Wednesday 20th to Friday 22nd August 2025. In addition, the awardee will be required to provide a written report on their further achievements (projects, presentations, publications, funding, community engagement) within 18 months of accepting the award. The award is for $50,000 together with a commemorative plaque.

To be eligible for this award, applicant must be:

• A financial member of ADS for at least 12 months at time of application (must have joined as a member of ADS no later than May 2024 and paid subscription for 2025) and who has provided significant contributions to clinical diabetes research 
• Up to 20 years post-doctoral degree or equivalent e.g FRACP
• Australian-based
• Provide a 1-page overview of how the award funds will further assist their ongoing clinical diabetes research
• Available to present the award lecture at the Australasian Diabetes Congress in 2025 in person.

Applications, accompanied by a full curriculum vitae, are now invited and should be in the form of a letter not exceeding 2 pages outlining the applicant’s suitability for the award and a 1 page overview of how the award funds will further assist their ongoing clinical diabetes research. Previous recipients are ineligible to re-apply for this award.

2025 ADS Ranji and Amara Wikramanayake Clinical Diabetes Research Award applications have now closed.

Applications Closing Date: Monday, 12 May 2025 – CLOSED

2025 ADS Australasian Diabetes Congress Awards

A number of awards and grants are available for ADS members attending the 2025 Australasian Diabetes Congress that will be held at the Gold Coast Convention and Exhibition Centre in QLD from Wednesday 20th to Friday 22nd August 2025. Please see below for all ADS ADC Awards and Grants on offer for 2025:

ADS Poster Awards

ADS Poster Awards for both Discovery Science and Clinical Research will be on offer during the 2025 ADS/ADEA Australasian Diabetes Congress. ADS Poster Awards are to the value of $500 each.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
   (must have joined as a member of ADS no later than May 2024 and paid subscription for 2025)
2. Applicants must be an early career researcher
3. You must be available to present at the time of the poster session
4. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
5. Previous winners of this award are in-eligible to apply

Please ensure that you upload your supporting documentation.

• 2025 ADS ADC Awards applications have now closed.

Applications Closing Date: Monday, 26 May 2025 – CLOSED

ADS Pincus Taft Young Investigator Award

The ADS-Pincus Taft Young Investigator Award is to the value of $2000. The finalists will be categorised into Discovery Science and the award will be given to the best oral presentation by an early career ADS member at the Australasian Diabetes Congress as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
   (must have joined as a member of ADS no later than May 2024 and paid subscription for 2025)
2. Applicants must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award 6-8 applicants will be selected from abstracts to present in the ADS-Pincus Taft Young Investigators Session.

Please ensure that you upload your supporting documentation.

• 2025 ADS ADC Awards applications have now closed.

Applications Closing Date: Monday, 26 May 2025 – CLOSED

ADS President’s Young Investigator Award

The ADS President’s Young Investigator Award is to the value of $2000. The finalists will be categorised into Clinical Research and the award will be given to the best oral presentation by an early career ADS member at the Australasian Diabetes Congress as judged by peer review and a committee appointed by the ADS Council.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
   (must have joined as a member of ADS no later than May 2024 and paid subscription for 2025)
2. Applicants must not be more than 2 years beyond the award of a doctoral degree (PhD, MD) or fellowship (FRACP)
3. Each applicant must provide a supporting statement including one signed by his/her supervisor or department head, indicating that the work presented is substantially the candidate’s own work
4. Previous winners of this award are in-eligible to apply
5. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award 6-8 applicants will be selected from abstracts to present in the ADS Presidents Young Investigators Session.

Please ensure that you upload your supporting documentation.

• 2025 ADS ADC Awards applications have now closed.

Applications Closing Date: Monday, 26 May 2025 – CLOSED

2025 ADS Clinical Presentation Award in memory of Dr Paul Lee

The ADS Clinical Presentation Award in memory of Dr Paul Lee is to the value of $1,250. The finalists will be categorised into Clinical Research and the award will be given to the most outstanding oral presentation by an ADS early career member at the 2025 Australasian Diabetes Congress that will be held at the Gold Coast Convention and Exhibition Centre in QLD from Wednesday 20th to Friday 22nd August 2025 and judged by peer review and a committee appointed by the ADS Council. 2019 was the inaugural year of this annual award.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
   (must have joined as a member of ADS no later than May 2024 and paid subscription for 2025)
2. Applicants must be a mid-career clinical researcher (4-10 years post-doctoral)
3. Each applicant must provide a supporting statement indicating that the work presented is substantially their own work
4. 6-8 applicants will be selected from the submitted abstracts to present in the award session
5. Previous winners of this award are in-eligible to apply
6. Finalist applicants must present work of abstract submitted for the conference; if not they will be in-eligible to receive the award

Please ensure that you upload your supporting documentation.

• 2025 ADS ADC Awards applications have now closed.

Applications Closing Date: Monday, 26 May 2025 – CLOSED

2025 ADS Jeff Flack Diabetes Data Award

The Australian Diabetes Society (ADS) invites nominations for the 2025 ADS Jeff Flack Diabetes Data Award for an Australian researcher who has made an outstanding contribution to Diabetes data collection in Australia. The Award will be considered by a review committee consisting of prominent Australian diabetes researchers with the option to co-opt international referees. The nominee must be a financial member of the ADS (paid subscription for 2025) and have been a member for at least 12 months at the time of their nomination for this award (must have joined as a member of ADS no later than May 2024). At least one of the Nominator/s must be an ADS member and nominations can be self-initiated or initiated by colleagues. The award will include a $5,000 honorarium together with a commemorative plaque.

Categories of merit include:

• Multiple / Significant / Substantial Publications (or In Press) involving data collection, collation, analysis and reporting (beyond ‘routine day-to-day’ minimum dataset collection);
• Something ‘Novel’ regarding data collection / reporting – development of data systems;
• Substantial contribution to data issues (attendance / chair of Committee(s) on data issues – developing standards etc);
• List the best 5 or 10 relevant publications;
• Highlight all relevant publications in your CV.

Nominations should include a letter (not exceeding 2 pages) clearly stating the basis of the nomination and a full curriculum vitae.

2025 ADS Jeff Flack Diabetes Data Award nominations have now closed.

Nominations Closing Date: Monday, 19 May 2025 – CLOSED

2025 ADS Diabetes Research Seed Grants

The Australian Diabetes Society (ADS) Council is pleased to announce a call for applications for ADS Diabetes Research Seed Grants in 2025. This is a new funding opportunity being offered this year by the ADS. The purpose of the grants is to provide seed funds for new projects or early stage research projects. Early/Mid Career Researchers (EMCRs) are highly encouraged to apply for these grants.

Six grants will be offered and up to the value of A$20,000 each. Applications in all areas of diabetes research will be considered.

Projects must be applicable to diabetes care in Australia. The Principal Investigator must be a financial member of the ADS for at least one year at the time of application (must have joined as a member of ADS no later than May 2024 and paid membership fees to 30 June 2026). Applicants can have either a clinical or discovery (basic) science qualification.

Grant applications are to be submitted in the format: title, background, aims, methods, expected contribution to diabetes, project plan, ethics approval (if relevant) and a detailed budget. Grant applications must be NO longer than four A4 pages with a minimum font size of 12 (includes references). Applications must be accompanied by a full curriculum vitae. A full report on the outcome of the work must be submitted to ADS and the awardee is expected to present their work at the 2027 Australasian Diabetes Congress and must include acknowledgement of the Australian Diabetes Society of the grant support including any publication(s).

Please note: Only one grant application is permitted per applicant. All applications will be screened by the Grant Review Committee which will comprise members of the Australian Diabetes Society Council and external reviewers. The Grant Review Committee reserves the right to reject any application prior to review if it does not comply with the criteria or the purpose of this grant scheme. There will be no feedback provided to unsuccessful applications.

2025 ADS Diabetes Research Seed Grant applications have now closed.

Applications Closing Date: Friday, 30 May 2025 – CLOSED

2025 ADS Lifetime Achievement Award

The Australian Diabetes Society invites nominations for the 2025 ADS Lifetime Achievement Award.

Eligibility:
The Lifetime Achievement Award recognises an individual who has:

1. An established history of distinguished service to education, clinical practice and/or research and training in diabetes
2. Made a lasting contribution to diabetes
3. Exhibited leadership and mentorship in diabetes research and/or clinical practice on a state, national and/or international level

Selection of the nominee is made on the basis of the candidate’s significant, fundamental contributions to diabetes (whether in research, clinical practice, leadership, mentorship or other); the lasting impact of these contributions to the sector; and the demonstration of a lifetime commitment to diabetes.

Nominees must have:

1. Made a positive impact to diabetes [at either state/territory or national level]
2. The respect of professional peers
3. General acknowledgement as having reached a pinnacle of their profession
4. Demonstrated, over an extended period of time, a contribution which has included either research and/or clinical practice, professional leadership and service to the diabetes community
5. Held positions of leadership
6. Personal integrity
7. On-going membership with the ADS

Nominees awarded the 2025 ADS Lifetime Achievement Award will be announced at the 2025 ADS Annual General Meeting.

Please submit two letters of recommendation including a full curriculum vitae of the nominee. One letter of recommendation must be by a financial member of the ADS (paid subscription for 2025).

2025 ADS Lifetime Achievement Award nominations have now closed.

Nominations Closing Date: Monday, 23 June 2025 – CLOSED

RACP Australian Diabetes Society Research Establishment Fellowship

The Royal Australasian College of Physicians (RACP) and the Australian Diabetes Society (ADS) are pleased to invite applications for the 2026 RACP Australian Diabetes Society Research Establishment Fellowship.

Eligibility criteria is as follows:

Purpose: To assist a current or future RACP Fellow in establishing a career in diabetes research. Research may relate to any form of diabetes and be from any domain, including basic, clinical, epidemiological, health services or translational research.
Value: Up to $50,000 for 1 year.
Eligibility: Australian Fellows or Advanced Trainees of the RACP’s Divisions, Faculties and Chapters, who are current financial members of the Australian Diabetes Society for at least 12 months prior to the submission date.
Tenable: Australia only.
Special requirements: Recipients must present their research findings at the Australasian Diabetes Congress within 2 years.

Read the terms and conditions carefully before submitting your application.

To apply: Please complete the online application form.

The Fellowship is made available by a grant from the Australian Diabetes Society, matched with funds provided by members of the RACP.

Applications Closing Date: Tuesday, 8 July 2025

For further information please visit the RACP website at Research Establishment Fellowships (racp.edu.au)

2025 ADS Australasian Diabetes Congress Travel Grants

This year a number of ADS Travel Grants will be awarded to junior investigators who have an abstract accepted for presentation at the 2025 Australasian Diabetes Congress that will be held at the Gold Coast Convention and Exhibition Centre in QLD from Wednesday 20th to Friday 22nd August 2025. The number and size of grants will be determined according to the number and suitability of applications and the funds available. The travel grants will provide a significant contribution to the individuals travel costs to attend the congress. Applications will be prioritised using abstract review scores.

Eligibility is as follows:

1. A financial member of the ADS for 12 months at the time of application
   (Applicant must have joined as a member of ADS no later than July 2024 and paid subscription to 30 June 2026 with no outstanding arrears at the time of application)
2. In training for a higher degree e.g. PhD, MD, fellowship or medical specialty
3. Supported by a statement from the candidate’s supervisor or department head indicating the nature of their present position and the availability of other sources of financial support for their registration to the congress
4. Travel Grants will be made directly to the member and not their respective institution
5. Applicant must be the presenting author and abstracts must be submitted and accepted for sessions within the ADS program only (clinical or discovery science)
6. Applicant must not live within the local city of where the ADC is being hosted e.g. Gold Coast
7. Applicant must attend the ADC in person and present their abstract

Note: Applicants must not be in receipt of a grant from any other body to attend the Australasian Diabetes Congress (ADC) or a meeting in association with the ADC.

Please ensure that you upload your supporting documentation. The successful applicants will be advised in writing one week prior to the congress and travel grants will be paid following the ADC.

• To apply: Please complete the online application form.

Applications Closing Date: Monday, 14 July 2025

2025 ADS Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research

The Australian Diabetes Society together with the Lindsey Baudinet Family is pleased to announce the 2025 ADS Lindsey Baudinet Rising Star Award in Type 1 Diabetes Research. The purpose of the award is to support eligible early-career researchers to pursue research in type 1 diabetes and its complications. The award is $20,000 for one year.

To be eligible for this award, you need to:

• Be a financial member of ADS (paid subscription for 2025) for at least 12 months at the time of application (must have joined as a member of ADS no later than June 2024)
• Be Australian-based
• Be no more than 10 years post-doctoral at the time of application
• Be with a mentor or in a research group/department/institute with a proven track record of supporting emerging researchers for success.
• Be undertaking clinical or preclinical research in type 1 diabetes and its complications
• Be an outstanding early-career researcher
• Previous recipients are ineligible to re-apply for this award.

The selection committee will assess applicants based on:

• Project proposal
• CV
• Referee reports
• Demonstrated research excellence
• Demonstrated financial need
• Career aspiration

To apply: Details to be advised.

Applications Closing Date: TBA

Diabetes Australia Research Program Grants for 2025

Diabetes Australia is dedicated to reducing the incidence and impact of diabetes on people, health systems and society. We work with people living with or at risk of diabetes, their families and carers, health professionals, researchers, funders, other diabetes organisations and the community to positively change people’s lives.

In 2025, Diabetes Australia will provide vital funding for diabetes research projects across Australia, including:

• A limited number of General Grants for 2025 that will be offered to 2024 General Grant Applicants that attained a fundable score following a rigorous competitive peer-review process conducted in late 2023.
• Two $150,000 Millennium Awards: one for type 1 diabetes and one for type 2 diabetes. Applications close 31 July 2024 – CLOSED.
• One $150,000 Charles Campbell Coghlan OAM Emerging Researcher Award for an early to mid-career researcher. Applications close 31 July 2024 – CLOSED.
• A new category of Grants – Diabetes Community Priorities Grants. Four Grants of up to $100,000 each. Applications close 28 February 2025 – CLOSED.

Applications for the 2025 Grant Round have now closed.

Application forms and further information are available at www.diabetesaustralia.com.au/diabetes-australia-research-program

Applications Closing Date for Diabetes Community Priorities Grants: Friday, 28 February 2025 – CLOSED
Applications Closing Date for Millennium and Coghlan Awards: Wednesday, 31 July 2024 – CLOSED

The Australian Diabetes Society is proud to support a general grant to the value of $60,000 towards DARP.

2025 ADS-AstraZeneca Diabetes Research Grant

One grant will be offered and up to the value of $20,000. This grant has been made possible through the generosity of AstraZeneca who have strongly supported diabetes research over many years. 

Grant proposals must involve improvement of patient care and be consistent with the following identified national diabetes priorities to:

• Reduce the prevalence and incidence of people developing type 2 diabetes
• Promote earlier detection of diabetes
• Reduce the occurrence of diabetes-related complications (e.g. chronic kidney disease and heart failure) and improve quality of life among people with diabetes
• Reduce the impact of diabetes in Aboriginal and Torres Strait Islander peoples and other high risk groups
• Strengthen prevention and care through research, evidence and data.

Projects must be applicable to diabetes care in Australia. The Principal Investigator must be a financial member (paid subscription to 30 June 2026) of the ADS for at least one year at the time of application. Grant applications are to be submitted in the format: title, background, aims, methods, expected contribution to patient care, project plan, ethics approval (if relevant) and a detailed budget. Grant applications must be NO longer than four A4 pages with a minimum font size of 12 (includes references). Applications must be accompanied by a full curriculum vitae. A brief report on the outcome of the work must be submitted to ADS and the awardee is expected to present their work at the 2027 Australasian Diabetes Congress and must include acknowledgement of the Australian Diabetes Society and AstraZeneca of the grant support.

Please note: Only one grant application is permitted per applicant. All applications will be screened by the Grant Review Committee which will comprise members of the Australian Diabetes Society Council and external reviewers. The Grant Review Committee reserves the right to reject any application prior to review if it does not comply with the criteria or the purpose of this grant scheme. There will be no feedback provided to unsuccessful applications. Previous recipients of the ADS-AstraZeneca Diabetes Research Grants are ineligible to re-apply.

To apply: Details to be advised.

Applications Closing Date: TBA

2026 ADS-Skip Martin Early Career Fellowship

Fellowship Amount: $80,000 for one year plus a travel/conference allowance of up to $5,000.

Eligibility Criteria is as follows:

• Applicant must be a financial ADS member (paid subscription to 30 June 2026) for at least one year at the time of application
• The fellowship must commence by 30 June, 2026
• The applicant must be less than 6 years post-doc as of December, 2025 (excluding career disruptions)
• Applicant must provide a statement that the fellowship is for salary support and is not for support towards a grant/consumables.
• Applicant must notify ADS of any fellowship applications currently pending (e.g. NHMRC)
• The fellow must take up a position in Australia for the duration of the award
• The project must be diabetes related
• Previous recipients of this fellowship are ineligible to re-apply

Conditions of the Fellowship include the following:

• Award of PhD is not required at the time of application but a PhD must be awarded by the time of commencement
• The award cannot be held in conjunction with another major fellowship. If the highest ranking applicant is successful with another fellowship application or grant providing salary support, they must notify ADS and the next suitable candidate will be offered the award
• ADS reserves the right to not award the fellowship if there is no eligible applicant of sufficiently high standard
• The fellow must present their work at the 2027 Australasian Diabetes Congress
• The fellow must acknowledge the Australian Diabetes Society in publications related to the work
• At the conclusion of the research project, the applicant must provide a report of 1-2 A4 pages outlining the outcomes of the project

To apply: Details to be advised.

Applications Closing Date: TBA